These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7492083)

  • 1. Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.
    Mizojiri K; Futaguchi S; Norikura R; Katsuyama Y; Nagasaki T; Yoshimori T; Nakanishi M
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1445-53. PubMed ID: 7492083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
    Totsuka K; Shimizu K; Konishi M; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):757-61. PubMed ID: 1503437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
    Nakashima M; Uematsu T; Oguma T; Yoshida T; Mizojiri K; Matsuno S; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):762-8. PubMed ID: 1503438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine status and safety after administration of S-1108, a new oral cephem, to patients.
    Shimizu K; Saito A; Shimada J; Ohmichi M; Hiraga Y; Inamatsu T; Shimada K; Tanimura M; Fujita Y; Nishikawa T
    Antimicrob Agents Chemother; 1993 May; 37(5):1043-9. PubMed ID: 8517691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
    Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat.
    Diep QN; Bøhmer T; Skrede S
    Biochim Biophys Acta; 1995 Jan; 1243(1):65-70. PubMed ID: 7827109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine and glucuronic acid conjugates of pivalic acid.
    Vickers S; Duncan CA; White SD; Ramjit HG; Smith JL; Walker RW; Flynn H; Arison BH
    Xenobiotica; 1985 Jun; 15(6):453-8. PubMed ID: 4036169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanism for species difference on the toxicity of pivalic acid between dogs and rats.
    Yamaguchi T; Nakajima Y; Nakamura Y
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):61-8. PubMed ID: 16430936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Konishi M; Hashimoto H
    J Pharm Sci; 1992 Oct; 81(10):1038-41. PubMed ID: 1432617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats.
    Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE
    Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental transfer and pharmacokinetics of a single oral dose of [14C]p-nitrophenol in rats.
    Abu-Qare AW; Brownie CF; Abou-Donia MB
    Arch Toxicol; 2000 Sep; 74(7):388-96. PubMed ID: 11043494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
    Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic disposition of Rolziracetam in laboratory animals.
    Black A; Chang T
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):135-43. PubMed ID: 3691579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs.
    Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.